Diagnostic accuracy of short-time inversion recovery sequence in Graves’ ophthalmopathy before and after prednisone treatment

[1]  J. Eastwood,et al.  What's in a name? Eponyms in head and neck imaging. , 2010, Clinical radiology.

[2]  A. Kaim,et al.  Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves’ orbitopathy—a pilot study at 1.5 T , 2010, Neuroradiology.

[3]  E. Kirsch,et al.  Graves' orbitopathy: current imaging procedures. , 2009, Swiss medical weekly.

[4]  L. Leibovici,et al.  Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. , 2009, The Journal of clinical endocrinology and metabolism.

[5]  P. Perros,et al.  Thyroid-associated orbitopathy: who and how to treat. , 2009, Endocrinology and metabolism clinics of North America.

[6]  M. Nardi,et al.  Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. , 2008, Thyroid : official journal of the American Thyroid Association.

[7]  M. Nardi,et al.  Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. , 2008, European journal of endocrinology.

[8]  W. Wiersinga,et al.  Graves' orbitopathy : a multidisciplinary approach , 2007 .

[9]  M. Mourits.  Diagnosis and Differential Diagnosis of Graves’Orbitopathy , 2007 .

[10]  G. Lennerstrand,et al.  Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. , 2007, Acta ophthalmologica.

[11]  M. Nardi,et al.  Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. , 2006, European journal of endocrinology.

[12]  P. Goddard,et al.  Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. , 2006, European journal of radiology.

[13]  P. Goddard,et al.  Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease , 2005 .

[14]  A. Pinchera,et al.  Outcome of radioiodine‐131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study , 2005, Clinical endocrinology.

[15]  Y. Altuntas,et al.  Evaluation of Extraocular Muscles in the Edematous Phase of Graves Ophthalmopathy on Contrast-Enhanced Fat-Suppressed Magnetic Resonance Imaging , 2004, Journal of computer assisted tomography.

[16]  C. Hess,et al.  Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy? , 2002, The British journal of radiology.

[17]  S. Nagataki,et al.  Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. , 2002, Thyroid : official journal of the American Thyroid Association.

[18]  P. Perros,et al.  Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment , 2001, Clinical endocrinology.

[19]  P. Goddard,et al.  Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease , 2001, Eye.

[20]  F. Zonneveld,et al.  The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy , 2001, Clinical endocrinology.

[21]  E. Mezosi,et al.  Graves' ophthalmopathy: eye muscle involvement in patients with diplopia. , 2000, European journal of endocrinology.

[22]  W. Wiersinga,et al.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy , 1997, Clinical endocrinology.

[23]  P. F. Winter,et al.  MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. , 1995, Thyroid : official journal of the American Thyroid Association.

[24]  L Koornneef,et al.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. , 1989, The British journal of ophthalmology.

[25]  H. Noguchi,et al.  Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy. , 2010, Endocrine journal.

[26]  T. Taoka,et al.  Enhancement pattern of normal extraocular muscles in dynamic contrast-enhanced MR imaging with fat suppression. , 2000, Acta radiologica.

[27]  Y. Amano,et al.  Normal contrast enhancement of extraocular muscles: fat-suppressed MR findings. , 1997, AJNR. American journal of neuroradiology.

[28]  J. Orcutt,et al.  Graves' ophthalmopathy. , 1992, The Western journal of medicine.

[29]  C. Gorman,et al.  Pathogenesis of Graves' ophthalmopathy. , 1989, Developments in ophthalmology.